Outline the principles of who, when and how carrier screening should be implemented. |
|
|
|
|
|
|
Adhere to the technical standards and guidelines for Cystic Fibrosis carrier screening and Spinomuscular Atrophy |
|
|
|
|
|
|
Describe the principles, techniques and practices of Fragile X screening. |
|
|
|
|
|
|